Hebei Weizhan Medical Technology Co., Ltd. was established in February 2018 with a registered capital of 20 million yuan. It is a high-tech enterprise specializing in the research and development, production, and sales of minimally invasive surgical instruments and consumables (MISIA), medical biological dressings, and home health care products.

  In 2020, through the R&D team's difficult PR efforts and overcoming the impact of the epidemic, we successfully obtained 15 patents.

  Weizhan Medical is committed to providing high-quality products and services to doctors, and is dedicated to the cause of human health. We are committed to becoming a domestic platform for minimally invasive surgical instruments and consumables (MISIA), a platform for the transformation of medical biological dressing new materials into industry university research, and a rich product portfolio to provide one-stop solutions for minimally invasive surgical procedures and inpatient nursing in clinical departments such as obstetrics and gynecology, general surgery, urology, thoracic surgery, and nursing.

  Weizhan Medical has established domestic key hospital expert workstations, university joint research and development centers, enterprise high-tech research centers, and other industry university research platforms to develop various medical consumables products that meet clinical needs.

  The company has established a sound quality management system and has passed ISO 13485 and ISO 9001 international quality management system certifications. It has gradually completed ISO 45001 occupational health and safety management system certification and ISO 14001 environmental management system certification, and its main products have completed CE certification.

  The company's products are sold to over 200 hospitals in China (including more than 50 tertiary hospitals) through its extensive sales network, covering more than 20 provinces, municipalities, and autonomous regions, and establishing a comprehensive after-sales service system.